Walleye Trading
PVLA

Walleye Trading’s Palvella Therapeutics PVLA Stock Holding History

Walleye Trading’s Portfolio PVLA Stock Details PVLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-269
Closed -$162 – 4869
2017
Q4 		$162 Buy
+269
New +$125K ﹤0.01% 3595
2017
Q2 		– Sell
-176
Closed -$37 – 5025
2017
Q1 		$37 Buy
176
+153
+665% +$27.1K ﹤0.01% 3918
2016
Q4 		$3K Hold
23
– – ﹤0.01% 4535
2016
Q3 		$3K Hold
23
– – ﹤0.01% 4642
2016
Q2 		$3K Sell
23
-17
-43% -$2.6K ﹤0.01% 5082
2016
Q1 		$6K Buy
+40
New +$5.63K ﹤0.01% 4912

Other funds holding PVLA

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return

Walleye Trading's PVLA Position: Q1 2018 in Review

Walleye Trading sold out of Palvella Therapeutics (PVLA) in Q1 2018, closing a stake of 269 shares — an estimated $162 sold.

Walleye Trading first reported a position in PVLA in Q1 2016 and held it in 6 quarters. The position peaked at $6K in Q1 2016. 115 funds tracked by Wall St. Rank hold PVLA as of Q1 2018.

  • Walleye Trading reported no remaining Palvella Therapeutics position as of Q1 2018 after selling out during the quarter.
  • Walleye Trading sold 269 Palvella Therapeutics shares in Q1 2018, an estimated $162.
  • Walleye Trading first reported a position in Palvella Therapeutics in Q1 2016 and held it in 6 quarters.
  • Walleye Trading's Palvella Therapeutics position peaked at $6K in Q1 2016.
  • 115 funds tracked by Wall St. Rank held Palvella Therapeutics as of Q1 2018.

Based on Walleye Trading's 13F filing for Q1 2018, filed 15 May 2018.